Theralink Technologies, Inc.
THER
$0.0001
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 635.40K | 606.80K | 732.70K | 694.50K | 544.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 635.40K | 606.80K | 732.70K | 694.50K | 544.20K |
| Cost of Revenue | 245.20K | 202.00K | 239.90K | 300.70K | 326.20K |
| Gross Profit | 390.10K | 404.60K | 492.80K | 393.90K | 218.20K |
| SG&A Expenses | 8.10M | 9.15M | 14.22M | 13.81M | 13.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.35M | 9.35M | 14.46M | 14.11M | 13.38M |
| Operating Income | -7.71M | -8.74M | -13.73M | -13.42M | -12.83M |
| Income Before Tax | -13.50M | -30.91M | -48.21M | -54.42M | -47.69M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.50 | -30.91 | -48.21 | -54.42 | -47.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.50M | -30.91M | -48.21M | -54.42M | -47.69M |
| EBIT | -7.71M | -8.74M | -13.73M | -13.42M | -12.83M |
| EBITDA | -7.51M | -8.53M | -13.52M | -13.22M | -12.64M |
| EPS Basic | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS Diluted | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 24.61B | 24.61B | 24.78B | 24.69B | 24.14B |
| Average Diluted Shares Outstanding | 39.60B | 39.60B | 39.78B | 24.69B | 24.14B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -0.04% | -0.15% | -0.29% |